SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001140361-24-002981
Filing Date
2024-01-22
Accepted
2024-01-22 06:05:42
Documents
6
Period of Report
2024-01-22

Document Format Files

Seq Description Document Type Size
1 FORM PREM14A ny20017467x1_prem14a.htm PREM14A 2040103
2 FILING FEES TABLE ny20017467x1_ex107.htm EX-FILING FEES 11745
3 logo_goldmansachs.jpg GRAPHIC 15819
4 logo_karuna.jpg GRAPHIC 58451
5 ny20017467x1_pc01.jpg GRAPHIC 767020
6 ny20017467x1_pc02.jpg GRAPHIC 489120
  Complete submission text file 0001140361-24-002981.txt   3884110
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-38958 | Film No.: 24547003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)